MediPharm Labs Corp (MEDIF)
0.0619
0.00 (0.00%)
USD |
OTCM |
May 17, 15:11
MediPharm Labs Total Liabilities (Quarterly): 8.241M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.241M |
| September 30, 2023 | 9.420M |
| June 30, 2023 | 10.95M |
| March 31, 2023 | 6.201M |
| December 31, 2022 | 6.992M |
| September 30, 2022 | 7.865M |
| June 30, 2022 | 8.284M |
| March 31, 2022 | 6.748M |
| December 31, 2021 | 7.227M |
| September 30, 2021 | 12.22M |
| June 30, 2021 | 15.05M |
| March 31, 2021 | 14.71M |
| December 31, 2020 | 31.23M |
| Date | Value |
|---|---|
| September 30, 2020 | 34.34M |
| June 30, 2020 | 45.06M |
| March 31, 2020 | 18.11M |
| December 31, 2019 | 28.79M |
| September 30, 2019 | 40.83M |
| June 30, 2019 | 40.52M |
| March 31, 2019 | 26.77M |
| September 30, 2018 | 0.0263M |
| June 30, 2018 | 0.0095M |
| March 31, 2018 | 0.0102M |
| December 31, 2017 | 0.0048M |
| September 30, 2017 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.201M
Minimum
Mar 2023
45.06M
Maximum
Jun 2020
18.57M
Average
12.22M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Venus Concept Inc | 107.10M |
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.20M |
| Shareholders Equity (Quarterly) | 39.96M |
| Debt to Equity Ratio | 0.0397 |
| Current Ratio | 3.372 |
| Net Debt Paydown Yield | -0.85% |